Benefits of dual bronchodilation with QVA149 once daily versus placebo, indacaterol, NVA237 and tiotropium in patients with COPD: The SHINE study

被引：0
|
作者：
Bateman, Eric [1 ]
Ferguson, Gary T. [2 ]
Barnes, Neil [3 ]
Gallagher, Nicola [4 ]
Green, Yulia [4 ]
Horton, Rachael [4 ]
Henley, Michelle [4 ]
Banerji, Donald [5 ]
机构：
[1] Univ Cape Town, Dept Med, Rondebosch, South Africa
[2] Pulm Res Inst Southeast Michigan, Pulm Dept, Livonia, MI USA
[3] Barts Hlth NHS Trust, London Chest Hosp, London, England
[4] Novartis Horsham Res Ctr, Resp Dept, Horsham, W Sussex, England
[5] Novartis Pharmaceut, Resp Dept, E Hanover, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
COPD; -; management; Bronchodilators;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
7248
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BENEFITS OF DUAL BRONCHODILATION WITH QVA149 ONCE DAILY VERSUS PLACEBO, INDACATEROL, NVA237 AND TIOTROPIUM IN PATIENTS WITH COPD: THE SHINE STUDY
    Frith, P.
    Thompson, P.
    Wark, P.
    Lindstrom, S.
    Bateman, E.
    RESPIROLOGY, 2013, 18 : 20 - 20
  • [2] QVA149 ONCE DAILY PROVIDES SUPERIOR BRONCHODILATION VERSUS INDACATEROL, GLYCOPYRRONIUM, TIOTROPIUM AND PLACEBO: THE SHINE STUDY
    Barnes, N.
    Bateman, E.
    Gallagher, N.
    Green, Y.
    Horton, R.
    Henley, M.
    Banerji, D.
    THORAX, 2012, 67 : A147 - A148
  • [3] Cardiovascular Safety of QVA149, a Combination of Indacaterol and NVA237, in COPD Patients
    Van de Maele, Boudewijn
    Fabbri, Leonardo M.
    Martin, Carmen
    Horton, Rachael
    Dolker, Michael
    Overend, Tim
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (06) : 418 - 427
  • [4] Dual Bronchodilation With Once-Daily Qva149 Provides Superior Bronchodilation Compared To Its Mono-Components And Tiotropium In All Subgroups Of Patients With COPD: The Shine Study
    Bateman, E. D.
    Welte, T.
    Hashimoto, S.
    Gallagher, N.
    Green, Y.
    Horton, R.
    Henley, M.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [5] Qva149 Once Daily Is Safe And Well Tolerated In Patients With COPD: The Shine Study
    Welte, T.
    Barnes, N.
    Nagase, T.
    Gallagher, N.
    Green, Y.
    Horton, R.
    Henley, M.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [6] Dual bronchodilation with QVA149 versus single bronchoditator therapy: the SHINE study
    Bateman, Eric D.
    Ferguson, Gary T.
    Barnes, Neil
    Gallagher, Nicola
    Green, Yulia
    Henley, Michelle
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1484 - 1494
  • [7] Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study
    Kerwin, Edward
    Hebert, Jacques
    Gallagher, Nicola
    Martin, Carmen
    Overend, Tim
    Alagappan, Vijay K. T.
    Lu, Yimeng
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (05) : 1106 - 1114
  • [8] Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: The ENLIGHTEN study
    Dahl, Ronald
    Chapman, Kenneth R.
    Rudolf, Michael
    Mehta, Rajendra
    Kho, Pearl
    Alagappan, Vijay K. T.
    Chen, Hungta
    Banerji, Donald
    RESPIRATORY MEDICINE, 2013, 107 (10) : 1558 - 1567
  • [9] Once-Daily Qva149 Provides Clinically Meaningful Improvements In Lung Function And Clinical Outcomes Versus Placebo, Indacaterol, Glycopyrronium, Tiotropium And Salmeterol/fluticasone In Patients With COPD
    Vogelmeier, C.
    Dahl, R.
    D'Urzo, T.
    Chen, H.
    Green, Y.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [10] Dual Bronchodilation With Qva149 Reduces COPD Exacerbations: The Spark Study
    Wedzicha, J. A.
    Decramer, M.
    Ficker, J.
    Taylor, A. Fowler
    D'Andrea, P.
    Arrasate, C.
    Berhane, I.
    Chen, H.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
12345